ProfileGDS4718 / 219212_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 90% 87% 81% 88% 88% 94% 92% 90% 85% 90% 88% 88% 86% 92% 92% 87% 86% 93% 91% 85% 89% 89% 88% 88% 89% 87% 89% 87% 88% 91% 89% 93% 88% 88% 88% 92% 87% 87% 88% 85% 90% 90% 79% 94% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.1989990
GSM549102patient 115, normal, homogenized [OPG study]8.7028887
GSM549104patient 119, normal, homogenized [OPG study]7.9928381
GSM549108patient 138, normal, homogenized [OPG study]8.7803388
GSM549119patient 077, normal, homogenized [OPG study]8.7983688
GSM549133patient 032, cancer, homogenized [OPG study]10.013294
GSM549139patient 042, cancer, homogenized [OPG study]9.5672192
GSM549099patient 107, normal, homogenized [OPG study]9.1174390
GSM549109patient 139, normal, homogenized [OPG study]8.3949385
GSM549110patient 046, normal, homogenized [OPG study]9.1725590
GSM549114patient 063, normal, homogenized [OPG study]9.0940588
GSM549122patient 082, normal, homogenized [OPG study]8.8840888
GSM549134patient 033, cancer, homogenized [OPG study]8.5743486
GSM549136patient 036, cancer, homogenized [OPG study]9.6760692
GSM549140patient 044, cancer, homogenized [OPG study]9.5110392
GSM549111patient 047, normal, homogenized [OPG study]8.7613887
GSM549113patient 057, normal, homogenized [OPG study]8.7009686
GSM549132patient 031, cancer, homogenized [OPG study]9.69893
GSM549137patient 038, cancer, homogenized [OPG study]9.3591391
GSM549142patient 047, cancer, homogenized [OPG study]8.1422885
GSM549100patient 110, normal, homogenized [OPG study]9.0193589
GSM549107patient 135, normal, homogenized [OPG study]9.0979889
GSM549115patient 068, normal, homogenized [OPG study]9.1291988
GSM549116patient 072, normal, homogenized [OPG study]9.0439688
GSM549120patient 078, normal, homogenized [OPG study]9.0832289
GSM549131patient 030, cancer, homogenized [OPG study]8.8850287
GSM549118patient 074, normal, homogenized [OPG study]9.1171289
GSM549129patient 027, cancer, homogenized [OPG study]8.7233187
GSM549123patient 088, normal, homogenized [OPG study]8.8538188
GSM549124patient 006, cancer, homogenized [OPG study]9.2132391
GSM549126patient 015, cancer, homogenized [OPG study]8.9680789
GSM549128patient 025, cancer, homogenized [OPG study]9.8252193
GSM549103patient 117, normal, homogenized [OPG study]8.7949488
GSM549117patient 073, normal, homogenized [OPG study]9.0709988
GSM549138patient 041, cancer, homogenized [OPG study]8.9109688
GSM549141patient 045, cancer, homogenized [OPG study]9.6375692
GSM549130patient 028, cancer, homogenized [OPG study]8.6702887
GSM549101patient 111, normal, homogenized [OPG study]8.7166487
GSM549105patient 128, normal, homogenized [OPG study]8.8104588
GSM549106patient 134, normal, homogenized [OPG study]8.6305185
GSM549112patient 048, normal, homogenized [OPG study]9.2937590
GSM549125patient 011, cancer, homogenized [OPG study]9.1345690
GSM549127patient 024, cancer, homogenized [OPG study]7.844179
GSM549135patient 035, cancer, homogenized [OPG study]9.9896594